The Novel Oral Typhoid Vaccine M01ZH09 Is Well Tolerated and Highly Immunogenic in 2 Vaccine Presentations
Open Access
- 1 August 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 192 (3) , 360-366
- https://doi.org/10.1086/431605
Abstract
BackgroundM01ZH09 (Salmonella enterica serovar Typhi [Ty2 aroC− ssaV−] ZH9) is a live oral-dose typhoid vaccine candidate. M01ZH09 was rationally modKeywords
This publication has 0 references indexed in Scilit: